437 related articles for article (PubMed ID: 24174329)
1. A genomics-based classification of human lung tumors.
;
Sci Transl Med; 2013 Oct; 5(209):209ra153. PubMed ID: 24174329
[TBL] [Abstract][Full Text] [Related]
2. Broad, Hybrid Capture-Based Next-Generation Sequencing Identifies Actionable Genomic Alterations in Lung Adenocarcinomas Otherwise Negative for Such Alterations by Other Genomic Testing Approaches.
Drilon A; Wang L; Arcila ME; Balasubramanian S; Greenbowe JR; Ross JS; Stephens P; Lipson D; Miller VA; Kris MG; Ladanyi M; Rizvi NA
Clin Cancer Res; 2015 Aug; 21(16):3631-9. PubMed ID: 25567908
[TBL] [Abstract][Full Text] [Related]
3. Cancer genomics of lung cancer including malignant mesothelioma: A brief overview of current status and future prospects.
Jhanwar SC; Xu XL; Elahi AH; Abramson DH
Adv Biol Regul; 2020 Dec; 78():100723. PubMed ID: 32992231
[TBL] [Abstract][Full Text] [Related]
4. Genomics AIDS lung tumor classification and treatment.
Cancer Discov; 2014 Jan; 4(1):OF5. PubMed ID: 24402957
[TBL] [Abstract][Full Text] [Related]
5. [Relevance of molecular alterations in histopathologic subtyping of lung adenocarcinoma based on 2011 International Multidisciplinary Lung Adenocarcinoma Classification].
Liu B; Shi SS; Wang X; Xu Y; Zhang XH; Yu B; Lu ZF; Wang JD; Zhou XJ
Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):505-10. PubMed ID: 23157740
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive comparative analysis of the histomorphological features of ALK-rearranged lung adenocarcinoma based on driver oncogene mutations: frequent expression of epithelial-mesenchymal transition markers than other genotype.
Kim H; Jang SJ; Chung DH; Yoo SB; Sun P; Jin Y; Nam KH; Paik JH; Chung JH
PLoS One; 2013; 8(10):e76999. PubMed ID: 24194854
[TBL] [Abstract][Full Text] [Related]
7. Chromosomal and genomic changes in lung cancer.
Varella-Garcia M
Cell Adh Migr; 2010; 4(1):100-6. PubMed ID: 20139701
[TBL] [Abstract][Full Text] [Related]
8. An algorithm for classifying tumors based on genomic aberrations and selecting representative tumor models.
Lu X; Zhang K; Van Sant C; Coon J; Semizarov D
BMC Med Genomics; 2010 Jun; 3():23. PubMed ID: 20569491
[TBL] [Abstract][Full Text] [Related]
9. [THE IMPACT OF MOLECULAR PROFILING USING NEXT-GENERATION SEQUENCING IN ADVANCED LUNG CANCER].
Belilovski Rozenblum A; Ilouze M; Dudnik E; Soussan-Gutman L; Dvir A; Peled N
Harefuah; 2017 Nov; 156(11):686-691. PubMed ID: 29198084
[TBL] [Abstract][Full Text] [Related]
10. Correlation of Somatic Genomic Alterations Between Tissue Genomics and ctDNA Employing Next-Generation Sequencing: Analysis of Lung and Gastrointestinal Cancers.
Toor OM; Ahmed Z; Bahaj W; Boda U; Cummings LS; McNally ME; Kennedy KF; Pluard TJ; Hussain A; Subramanian J; Masood A
Mol Cancer Ther; 2018 May; 17(5):1123-1132. PubMed ID: 29500272
[TBL] [Abstract][Full Text] [Related]
11. The Molecular Pathology of Lung Cancer.
Sholl LM
Surg Pathol Clin; 2016 Sep; 9(3):353-78. PubMed ID: 27523966
[TBL] [Abstract][Full Text] [Related]
12. Molecular heterogeneity of anti-PD-1/PD-L1 immunotherapy efficacy is correlated with tumor immune microenvironment in East Asian patients with non-small cell lung cancer.
Jin R; Liu C; Zheng S; Wang X; Feng X; Li H; Sun N; He J
Cancer Biol Med; 2020 Aug; 17(3):768-781. PubMed ID: 32944405
[No Abstract] [Full Text] [Related]
13. Genomic profiling of lung adenocarcinoma patients reveals therapeutic targets and confers clinical benefit when standard molecular testing is negative.
Lim SM; Kim EY; Kim HR; Ali SM; Greenbowe JR; Shim HS; Chang H; Lim S; Paik S; Cho BC
Oncotarget; 2016 Apr; 7(17):24172-8. PubMed ID: 26992220
[TBL] [Abstract][Full Text] [Related]
14. [Diagnosis, prognosis, and prediction of non-small cell lung cancer. Importance of morphology, immunohistochemistry and molecular pathology].
Warth A
Pathologe; 2015 Nov; 36 Suppl 2():194-200. PubMed ID: 26391251
[TBL] [Abstract][Full Text] [Related]
15. The introduction of systematic genomic testing for patients with non-small-cell lung cancer.
Cardarella S; Ortiz TM; Joshi VA; Butaney M; Jackman DM; Kwiatkowski DJ; Yeap BY; Jänne PA; Lindeman NI; Johnson BE
J Thorac Oncol; 2012 Dec; 7(12):1767-1774. PubMed ID: 23154547
[TBL] [Abstract][Full Text] [Related]
16. Predicting survival within the lung cancer histopathological hierarchy using a multi-scale genomic model of development.
Liu H; Kho AT; Kohane IS; Sun Y
PLoS Med; 2006 Jul; 3(7):e232. PubMed ID: 16800721
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Genomic Driver Oncogenes in Vietnamese Patients With Non-Small-Cell Lung Cancer in the United States and Vietnam.
Nguyen KH; Stehr H; Zhou L; Nguyen AH; Hiep PN; Van Cau N; Duy PC; Thorp R; Wakelee HA; Diehn M; Neal JW
J Glob Oncol; 2018 Nov; 4():1-9. PubMed ID: 30422746
[TBL] [Abstract][Full Text] [Related]
18. Translating genomic information into clinical medicine: lung cancer as a paradigm.
Levy MA; Lovly CM; Pao W
Genome Res; 2012 Nov; 22(11):2101-8. PubMed ID: 23019146
[TBL] [Abstract][Full Text] [Related]
19. The Landscape of Actionable Molecular Alterations in Immunomarker-Defined Large-Cell Carcinoma of the Lung.
Chan AW; Chau SL; Tong JH; Chow C; Kwan JSH; Chung LY; Lung RW; Tong CY; Tin EK; Law PP; Law WT; Ng CSH; Wan IYP; Mok TSK; To KF
J Thorac Oncol; 2019 Jul; 14(7):1213-1222. PubMed ID: 30978501
[TBL] [Abstract][Full Text] [Related]
20. Genomic Alterations in the RB Pathway Indicate Prognostic Outcomes of Early-Stage Lung Adenocarcinoma.
Choi S; Kim HR; Sung CO; Kim J; Kim S; Ahn SM; Choi CM; Chun SM; Choi EK; Kim SW; Kim YH; Lee JY; Song JS; Kim D; Haq F; Lee SY; Lee JE; Jung WR; Jang HY; Yang E; Lee C; Yu E; Kong G; Baek D; Jang SJ
Clin Cancer Res; 2015 Jun; 21(11):2613-23. PubMed ID: 25294902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
